UBS Maintains Buy on Omega Healthcare Invts, Raises Price Target to $54
أوميغا للرعاية الصحية
Omega Healthcare Investors, Inc. OHI | 0.00 |
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:
OHI) with a Buy and raises the price target from $52 to $54.
